HomeComparePKPH vs BTI

PKPH vs BTI: Dividend Comparison 2026

PKPH yields 129.03% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKPH wins by $11.91M in total portfolio value
10 years
PKPH
PKPH
● Live price
129.03%
Share price
$1.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.95M
Annual income
$4,733,958.72
Full PKPH calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — PKPH vs BTI

📍 PKPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKPHBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKPH + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKPH pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKPH
Annual income on $10K today (after 15% tax)
$10,967.74/yr
After 10yr DRIP, annual income (after tax)
$4,023,864.91/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, PKPH beats the other by $4,021,482.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKPH + BTI for your $10,000?

PKPH: 50%BTI: 50%
100% BTI50/50100% PKPH
Portfolio after 10yr
$5.99M
Annual income
$2,368,380.50/yr
Blended yield
39.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PKPH
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKPH buys
0
BTI buys
0
No recent congressional trades found for PKPH or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKPHBTI
Forward yield129.03%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$11.95M$37.8K
Annual income after 10y$4,733,958.72$2,802.29
Total dividends collected$10.93M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PKPH vs BTI ($10,000, DRIP)

YearPKPH PortfolioPKPH Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$23,603$12,903.23$11,301$601.08+$12.3KPKPH
2$53,719$28,463.34$12,799$706.58+$40.9KPKPH
3$118,021$60,542.03$14,527$832.38+$103.5KPKPH
4$250,593$124,310.20$16,527$982.75+$234.1KPKPH
5$514,813$246,678.79$18,846$1,162.95+$496.0KPKPH
6$1,024,469$473,618.88$21,545$1,379.49+$1.00MPKPH
7$1,977,016$880,834.70$24,694$1,640.41+$1.95MPKPH
8$3,704,035$1,588,627.70$28,378$1,955.69+$3.68MPKPH
9$6,744,972$2,781,654.52$32,702$2,337.79+$6.71MPKPH
10$11,951,079$4,733,958.72$37,794$2,802.29+$11.91MPKPH

PKPH vs BTI: Complete Analysis 2026

PKPHStock

Peak Pharmaceuticals, Inc. operates as a bio­pharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THC­free, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.

Full PKPH Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this PKPH vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKPH vs SCHDPKPH vs JEPIPKPH vs OPKPH vs KOPKPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.